Scientific Program > Poster Presentations

Plasma sources and plasma equipment used for cancer treatment

• Giovanni BUSCO, University of Orléans, France
• Changes in oxygen level upon plasma treatments: consequences for RONS production?
• Georg DAESCHLEIN, University of Greifswald, Germany
• Suitability of cold plasma for treatment of actinic keratosis
• Kristaq GAZELI, University of Paris-Saclay, France
• Optimization of the chemical reactivity of cold atmospheric pressure microplasmas for application in cell treatments
• David GRAVES, University of California Berkeley, United States of America
• Advanced control of plasma medical devices
• Kato SUSUMU, National Institute of Advanced Industrial Science and Technology, Japan
• Sustaining mechanism of low energy atmospheric pressure plasma jets
• Ali MESBAH, University of California Berkeley, United States of America
• Model predictive control of atmospheric pressure plasma jets for effective dose delivery
• Ekaterina SHERSHUNOVA, Russian Academy of Sciences, Russia
• DBD-source with regulated average power for plasma medicine

Plasma-cancer interactions: experiments, modeling and simulation

• Anthony CORDERO, University of Costa Rica, Costa Rica
• In vitro evaluation of radiobiological response to x-rays, in breast cancer cells exposed to atmospheric pressure plasmas
• Georg DAESCHLEIN, University of Greifswald, Germany
• Combined plasma-chemotherapy is more effective than chemotherapy and plasma alone and saves adverse effects
• Rico RUTKOWSKI, University of Greifswald, Germany
• Head and neck cancer treatment with cold atmospheric plasma (CAP) – Hyperspectral imaging of therapeutic effects
• Jonas VAN DER PAAL, University of Antwerp, Belgium
• In search of the plasmaporation mechanism during plasma treatment of skin
• Dayun YAN, George Washington University, United States of America
• The strong H₂O₂ production by cancer cells during the direct cold atmospheric plasma treatment

Destruction of cancer cells by plasmas

• James CURTIN, Dublin Institute of Technology, Ireland
• Cold atmospheric plasma induces autophagic-like features and cell death in brain cancer cells
• Natasa HOJNIK, Jozef Stefan Institute, Slovenia
• The mechanisms behind the inhibitory effects of cold atmospheric plasma against cancer cells
• Bruno HONNORAT, University Pierre and Marie Curie, France
• Therapeutic effect of cold atmospheric plasma on oral cavity squamous cell carcinomas
• Katarina KUCEROVA, Comenius University, Slovakia
• Indirect treatment of cancer cells by air spark and corona discharge
• Augusto STANCAMPIANO, University of Bologna, Italy
• Atmospheric non-equilibrium plasma induces cell death, cell-cycle arrest, apoptosis and oxidative stress pathway regulation in cancer cells

Mechanisms of plasma selectivity towards cancer cells

• Sander BEKESCHUS, INP Greifswald, Germany
• Mitochondrial inhibtion syngergizes with plasma to elicit potent tumor cell killing
• Emilio MARTINES, Consorzio RFX, Italy
• Role of intracellular RONS and hypoxia-inducible factor in plasma-based cancer treatment
• Warren ROWE, Jerome Canady Research Institute, United States of America
• The effect of the Canady Helios cold plasma scalpel on the selective elimination of cancer
• Steven VANUYTSEL, University of Antwerp, Belgium
• Plasma cancer treatment coming of age: comparing in vitro selectivity of radio-, chemo-, and plasma therapy on glioblastoma multiforme

Plasma-liquid interaction / plasma chemistry in biological liquids / plasma activated media for cancer applications

• Daniela BOEHM, Dublin Institute of Technology, Ireland
• Cytotoxic mediators in PAW and PAL – Hydrogen peroxide and beyond
• Marie BRETON, Institut Gustave Roussy, France
• Study of the effect of a cold atmospheric plasma jet on the chemistry of membranes
• Zhitong CHEN, George Washington University, United States of America
• Novel micro-cold atmospheric plasma device for cancer treatment
• Mohamed EL SHAER, University of Zagazig, Egypt
• Effect of plasma activated mist on breast cancer cells
• Bill GRAHAM, Queen's University Belfast, United Kingdom
• A study of non-thermal plasma-liquid chemistry
• Bruno HONNORAT, University Pierre and Marie Curie, France
• Spectrophotometric and fluorimetric determination of reactive oxygen and nitrogen species produced by plasma-liquid interactions
• Laurent INVERNIZZI, INU Champollion, France
• Chemical and electrical characterization of a liquid target treated by a He/O₂ plasma jet
• Laurent INVERNIZZI, University of Paris-Saclay, France
• Experimental study of plasma microjets as sources of reactive species for biomedical applications
• Mounir LAROUSSI, Old Dominion University, United States of America
• Comparative study on the viability of cancerous and non-cancerous epithelial cells treated by PAM
• Nofel MERBAHI, University of Toulouse, France
• Quantitative detection of radicals generated by plasma jet in culture medium
• Hiromasa TANAKA, Nagoya University, Japan
• Plasma activated medium and plasma activated ringer's lactate solution for cancer applications

Animal and clinical studies of cancer treatment by plasmas

• Vandana MILLER, Drexel University, United States of America
• Plasma created vaccine and vaccination strategy for immunotherapeutic control of deep tumors